(1S)-2,2-difluorocyclopropane-1-carboxylic acid, 95.0%, 1g

Ethyl 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine-2-carboxylate;hydrochloride, 98+%, 100mg

4-Butylbenzene-1,2-diol, 98%, 1g

1,2-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole, 98%, 1g

Methyl 4-amino-3-(methylamino)benzoate, 95.0%, 5g

(R,R)-(+)-N,N'-Bis(alfa-methylbenzyl)sulfamide, 99.0%, 1g

2-[(1R*,4R*)-4-Aminocyclohexyl]-7-fluoroisoindolin-1-one hydrochloride, 1g

METHYL 4-BROMO-2-IODO-BENZOATE, 97.0%, 100g

2-Bromo-3'-chloro-5'-fluorobenzophenone, 97.0%, 1g

Tert-butyl 4,4-dimethoxy-3-((methylsulfonyl)oxy)piperidine-1-carboxylate, 98%, 500mg

5-(Hydroxymethyl)piperidin-2-one, 95.0%, 250mg

p-Toluic acid, 98%, for synthesis, 1 kg, plastic packaging.

4-Fluoro-1H-indole-3-carbonitrile, 95.0%, 250mg